Brandes Investment Partners LP Holds Position in Barclays Plc (BCS); As Thermo Fisher Scientific (TMO) Share Price Declined, Veritas Investment Management Llp Trimmed Its Stake

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Veritas Investment Management Llp decreased its stake in Thermo Fisher Scientific Inc (TMO) by 1.57% based on its latest 2018Q3 regulatory filing with the SEC. Veritas Investment Management Llp sold 6,075 shares as the company’s stock declined 0.05% with the market. The institutional investor held 381,134 shares of the industrial machinery and components company at the end of 2018Q3, valued at $93.00M, down from 387,209 at the end of the previous reported quarter. Veritas Investment Management Llp who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $89.55B market cap company. The stock increased 0.62% or $1.36 during the last trading session, reaching $222.45. About 1.73 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 27.72% since December 30, 2017 and is uptrending. It has outperformed by 27.72% the S&P500. Some Historical TMO News: 24/05/2018 – Thermo Fisher Scientific Declares Quarterly Dividend; 12/04/2018 – Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR; 08/03/2018 Thermo Scientific Krios G3i Cryo-Electron Microscope Announced as 2018 Edison Awards Finalist; 01/05/2018 – S&PGR Upgrades Thermo Fisher Scientific To ‘BBB+’; Otlk Stable; 01/05/2018 – Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test; 16/04/2018 – Thermo Fisher Presenting at Conference Tomorrow; 15/03/2018 – Thermo Fisher Scientific Named IndustryWeek Best Plants Award Winner 2017; 30/04/2018 – MUDRICK SAYS THERMO ACQUISITIONS MERGER NOT IN BEST INTEREST; 25/04/2018 – GLOBALSTAR INC – MERGER TO ORGANIZE PRO FORMA CO INTO 4 PRINCIPAL OPERATING SUBSIDIARIES UNDER NAME THERMO COMPANIES INC AS PUBLIC COMPANY; 10/04/2018 – Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018

Brandes Investment Partners Lp increased its stake in Barclays Plc (BCS) by 4.97% based on its latest 2018Q3 regulatory filing with the SEC. Brandes Investment Partners Lp bought 168,616 shares as the company’s stock declined 18.46% with the market. The institutional investor held 3.56 million shares of the commercial banks company at the end of 2018Q3, valued at $31.85M, up from 3.39 million at the end of the previous reported quarter. Brandes Investment Partners Lp who had been investing in Barclays Plc for a number of months, seems to be bullish on the $32.62B market cap company. The stock increased 1.48% or $0.11 during the last trading session, reaching $7.54. About 6.10M shares traded or 22.30% up from the average. Barclays PLC (NYSE:BCS) has declined 25.68% since December 30, 2017 and is downtrending. It has underperformed by 25.68% the S&P500. Some Historical BCS News: 20/04/2018 – BARCLAYS – FCA,PRA PROPOSED THAT BARCLAYS BANK PLC, BARCLAYS BANK UK PLC WILL BE SUBJECT TO REQUIREMENTS TO REPORT TO FCA,PRA ON CERTAIN ASPECTS OF WHISTLEBLOWING PROGRAMMES; 29/03/2018 – EWE IS SAID TO HIRE BARCLAYS TO SELL TURKISH GAS ASSETS; 04/05/2018 – Barclays Global Monetary Policy Forecasts as of May 4 (Table); 10/04/2018 – Barclays, Bpifrance and CLSA Invest in Symphony; 06/03/2018 – FIRST REPUBLIC BANK FRC.N : BARCLAYS ADDS TO TOP PICK LIST; REPLACES WESTERN ALLIANCE BANCORP; 21/03/2018 – BARCLAYS CEO: HARD TO SUCCEED AS CONSUMER BANK OUT OF HOME MKT; 17/04/2018 – REG-BARCLAYS PLC Form 8.5 (EPT/NON-Rl)- CME GROUP INC; 19/03/2018 – REG-BARCLAYS PLC Form 8.5 (EPT/NON-Rl) – CME GROUP INC; 13/03/2018 – TOTAL SA TOTF.PA : BARCLAYS RAISES TARGET PRICE TO EUR 60 FROM EUR 57; 21/03/2018 – SALESFORCE.COM INC CRM.N : BARCLAYS RAISES TARGET PRICE TO $140 FROM $130; RATING OVERWEIGHT

Veritas Investment Management Llp, which manages about $948.33 million US Long portfolio, upped its stake in Cerner Corp (NASDAQ:CERN) by 69,645 shares to 844,345 shares, valued at $54.38 million in 2018Q3, according to the filing. It also increased its holding in Berkshire Hathaway Inc (BRKB) by 11,322 shares in the quarter, for a total of 347,870 shares, and has risen its stake in Laboratory Corp Of America Holdings (NYSE:LH).

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $3.19 EPS, up 14.34% or $0.40 from last year’s $2.79 per share. TMO’s profit will be $1.28 billion for 17.43 P/E if the $3.19 EPS becomes a reality. After $2.62 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 21.76% EPS growth.

Investors sentiment decreased to 0.85 in 2018 Q3. Its down 0.23, from 1.08 in 2018Q2. It turned negative, as 41 investors sold TMO shares while 434 reduced holdings. 111 funds opened positions while 295 raised stakes. 333.46 million shares or 0.38% more from 332.19 million shares in 2018Q2 were reported. Rockland invested in 62,030 shares or 1.85% of the stock. Thompson Siegel And Walmsley Limited Liability Com holds 0% or 420 shares in its portfolio. Maverick Cap Ltd accumulated 11,330 shares. Tributary Capital Mgmt Ltd Com holds 3,300 shares. Clarivest Asset Management Limited Liability Company reported 264,132 shares stake. State Of Alaska Department Of Revenue stated it has 58,894 shares. Moreover, C Worldwide Group Hldgs A S has 7.03% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2.24M shares. Arizona State Retirement holds 0.29% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 125,521 shares. Baillie Gifford And reported 0.63% stake. Consolidated Gp Limited owns 27,815 shares. Winslow Mgmt Ltd accumulated 1.48M shares. Stephens Inc Ar has invested 0.07% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Parametric Associates Limited Company accumulated 1.03 million shares. Longview Prns (Guernsey) Ltd reported 1.82% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Stifel Fincl Corporation has 0.4% invested in Thermo Fisher Scientific Inc. (NYSE:TMO).

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 16 have Buy rating, 0 Sell and 3 Hold. Therefore 84% are positive. Thermo Fisher Scientific has $280 highest and $140 lowest target. $215.11’s average target is -3.30% below currents $222.45 stock price. Thermo Fisher Scientific had 72 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, August 22 with “Hold”. The company was maintained on Thursday, April 26 by Morgan Stanley. The company was upgraded on Tuesday, December 8 by Goldman Sachs. Morgan Stanley maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Wednesday, April 11. Morgan Stanley has “Overweight” rating and $216 target. Jefferies maintained it with “Hold” rating and $195.0 target in Wednesday, September 27 report. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Cowen & Co on Wednesday, October 11. The rating was initiated by Argus Research on Tuesday, October 6 with “Buy”. On Thursday, July 23 the stock rating was maintained by Mizuho with “Buy”. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Friday, October 20. Jefferies has “Hold” rating and $205.0 target. The rating was maintained by Barclays Capital on Tuesday, July 19 with “Overweight”.

Since October 1, 2018, it had 0 insider purchases, and 5 sales for $39.04 million activity. On Monday, October 1 the insider CASPER MARC N sold $31.07 million. The insider Herrema Gregory J. sold 17,235 shares worth $4.26M. The insider Williamson Stephen sold $2.29M.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Thermo Fisher Scientific beats by $0.07, beats on revenue – Seeking Alpha” on October 24, 2018, also Seekingalpha.com with their article: “Thermo Fisher Scientific declares $0.17 dividend – Seeking Alpha” published on November 08, 2018, Seekingalpha.com published: “Thermo Fisher in-licenses CRISPR technologies – Seeking Alpha” on September 18, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher announces sixth licensing agreement for B•R•A•H•M•S PCT – Seeking Alpha” published on October 02, 2018 as well as Seekingalpha.com‘s news article titled: “Thermo Fisher CE marks Oncomine Dx target test – Seeking Alpha” with publication date: October 17, 2018.

Among 16 analysts covering Barclays plc (ADR) (NYSE:BCS), 6 have Buy rating, 3 Sell and 7 Hold. Therefore 38% are positive. Barclays plc (ADR) had 43 analyst reports since August 19, 2015 according to SRatingsIntel. Morgan Stanley upgraded the shares of BCS in report on Friday, March 17 to “Overweight” rating. The stock of Barclays PLC (NYSE:BCS) earned “Equal-Weight” rating by Morgan Stanley on Friday, November 20. The firm has “Underperform” rating by Macquarie Research given on Monday, April 24. The company was maintained on Monday, May 29 by Goldman Sachs. The stock of Barclays PLC (NYSE:BCS) earned “Buy” rating by Bank of America on Monday, November 20. On Tuesday, June 19 the stock rating was downgraded by Bank of America to “Neutral”. The company was downgraded on Thursday, October 5 by BNP Paribas. The stock of Barclays PLC (NYSE:BCS) earned “Neutral” rating by Credit Suisse on Friday, November 9. The firm has “Market Perform” rating given on Wednesday, March 16 by Wood. Bank of America downgraded the shares of BCS in report on Friday, December 9 to “Underperform” rating.

More notable recent Barclays PLC (NYSE:BCS) news were published by: Seekingalpha.com which released: “Fed finds four foreign-based banks `living wills’ lacking – Seeking Alpha” on December 21, 2018, also Seekingalpha.com with their article: “BCS, SBS among premarket gainers – Seeking Alpha” published on December 12, 2018, Investorplace.com published: “5 Low-Priced Stocks Under $10 for the New Year – Investorplace.com” on December 20, 2018. More interesting news about Barclays PLC (NYSE:BCS) were released by: Seekingalpha.com and their article: “Barclays’s $400M commodities trading loss comes to light: Bloomberg – Seeking Alpha” published on December 14, 2018 as well as Seekingalpha.com‘s news article titled: “Barclays looks to bolster Swiss private banking business: Reuters – Seeking Alpha” with publication date: December 05, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.